Skip to main content
Equibles

Matt Angel

CEO

Tempest Therapeutics, Inc. (TPST)

Board Member

Tempest Therapeutics, Inc. (TPST)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Matt Angel

Matt Angel is recorded as CEO and Board Member at Tempest Therapeutics, Inc. (TPST). Tempest Therapeutics, Inc. reported in an 8-K filed February 6, 2026 that Matt Angel was appointed Class I director, effective February 3, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed February 6, 2026 that Matt Angel was appointed President and Chief Executive Officer, effective February 3, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed November 19, 2025 that Matt Angel was appointed member of the Company's board of directors. Equibles holds 4 filed executive changes naming Matt Angel; each is listed under recent activity with its source filing.

“Dr. Angel was appointed to serve as the Company's President and Chief Executive Officer, succeeding Mr. Brady in such capacities, and as a member of the Board as a Class I director.”
Tempest Therapeutics, Inc. Form 8-K, filed February 6, 2026 · Read the filing
“Dr. Angel was appointed to serve as the Company's President and Chief Executive Officer, succeeding Mr. Brady in such capacities, and as a member of the Board as a Class I director.”
Tempest Therapeutics, Inc. Form 8-K, filed February 6, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Tempest Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.